Takeda Pharmaceutical Co Ltd ADR Cash Flow Quality Index
Takeda Pharmaceutical Co Ltd ADR cash flow quality index. Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow Quality Index of 3.41x as of December 2025. Operating cash flow of $360.04 Billion exceeds net income of $105.51 Billion, indicating high earnings quality where cash backs reported profits. Explore Takeda Pharmaceutical Co Ltd ADR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Cash flow quality index of Takeda Pharmaceutical Co Ltd ADR from 2000 to 2025. Historical Cash Flow Quality Index for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. See TAK equity financing ratio to measure how much of total assets are equity-financed.
Takeda Pharmaceutical Co Ltd ADR Cash Flow Quality Index by Year (2000–2025)
Takeda Pharmaceutical Co Ltd ADR cash flow quality index by year from 2000 to 2025. Year-by-year earnings quality comparison for Takeda Pharmaceutical Co Ltd ADR. For the full cash flow conversion analysis, see TAK cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 9.80x | $1.06 Trillion | $107.93 Billion | ▲ +97.0% |
| 2024 | 4.97x | $716.34 Billion | $144.07 Billion | ▲ +61.3% |
| 2023 | 3.08x | $977.16 Billion | $317.04 Billion | ▼ -36.8% |
| 2022 | 4.88x | $1.12 Trillion | $230.17 Billion | ▲ +81.6% |
| 2021 | 2.69x | $1.01 Trillion | $376.17 Billion | ▼ -82.2% |
| 2020 | 15.12x | $669.75 Billion | $44.29 Billion | ▲ +401.9% |
| 2019 | 3.01x | $328.48 Billion | $109.01 Billion | ▲ +48.9% |
| 2018 | 2.02x | $377.85 Billion | $186.71 Billion | ▼ -10.6% |
| 2017 | 2.26x | $261.36 Billion | $115.51 Billion | ▲ +641.0% |
| 2016 | 0.31x | $25.49 Billion | $83.48 Billion | ▼ -77.4% |
| 2014 | 1.35x | $148.34 Billion | $109.56 Billion | ▼ -42.9% |
| 2013 | 2.37x | $307.71 Billion | $129.71 Billion | ▲ +78.0% |
| 2012 | 1.33x | $336.57 Billion | $252.48 Billion | ▲ +51.5% |
| 2011 | 0.88x | $326.94 Billion | $371.57 Billion | ▼ -4.0% |
| 2010 | 0.92x | $381.17 Billion | $415.83 Billion | ▲ +12.0% |
| 2009 | 0.82x | $326.27 Billion | $398.55 Billion | ▲ +61.5% |
| 2008 | 0.51x | $292.50 Billion | $576.84 Billion | ▲ +51.5% |
| 2007 | 0.33x | $209.28 Billion | $625.38 Billion | ▼ -53.6% |
| 2006 | 0.72x | $373.57 Billion | $517.96 Billion | ▲ +7.6% |
| 2005 | 0.67x | $295.54 Billion | $441.10 Billion | ▼ -3.9% |
| 2004 | 0.70x | $311.12 Billion | $446.14 Billion | ▲ +14.3% |
| 2003 | 0.61x | $263.45 Billion | $431.90 Billion | ▼ -40.3% |
| 2002 | 1.02x | $240.59 Billion | $235.66 Billion | ▲ +26.3% |
| 2001 | 0.81x | $212.66 Billion | $263.08 Billion | ▼ -39.2% |
| 2000 | 1.33x | $158.96 Billion | $119.62 Billion | — |